Platelets and antiplatelet therapy in ischemic heart disease.
D000787:Angina Pectoris / Q000097:blood / Q000188:drug therapy; D000800:Angioplasty, Balloon; D001161:Arteriosclerosis / Q000097:blood / Q000209:etiology; D001241:Aspirin / Q000627:therapeutic use; D001792:Blood Platelets / Q000187:drug effects* / Q000502:physiology; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D016861:Cyclooxygenase Inhibitors; D004176:Dipyridamole / Q000627:therapeutic use; D011464:Epoprostenol / Q000502:physiology; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy / Q000401:mortality / Q000517:prevention & control; D010973:Platelet Adhesiveness; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013931:Thromboxanes / Q000502:physiology
D016861:Cyclooxygenase Inhibitors; D013931:Thromboxanes; D004176:Dipyridamole; D011464:Epoprostenol; D001241:Aspirin; D013442:Sulfinpyrazone